APRE

Aprea Therapeutics (APRE)

Aprea Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:APRE

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/17	21 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2024/05/14	21 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2024/05/14	21 : 35	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APRE	Aprea Therapeutics Inc
2024/02/07	07 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2024/02/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:APRE	Aprea Therapeutics Inc
2024/02/03	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2024/01/26	21 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2024/01/26	20 : 03	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:APRE	Aprea Therapeutics Inc
2024/01/05	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/11/10	06 : 20	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:APRE	Aprea Therapeutics Inc
2023/11/10	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/11/10	06 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APRE	Aprea Therapeutics Inc
2023/10/17	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/10/13	20 : 31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/09/11	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/25	10 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/25	10 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/25	10 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/24	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/10	20 : 39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:APRE	Aprea Therapeutics Inc
2023/08/10	20 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/07/11	20 : 40	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:APRE	Aprea Therapeutics Inc
2023/07/11	20 : 30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:APRE	Aprea Therapeutics Inc
2023/07/06	05 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:APRE	Aprea Therapeutics Inc
2023/06/14	21 : 00	GlobeNewswire Inc.	Aprea Therapeutics to Present at Maxim Virtual Healthcare Conference	NASDAQ:APRE	Aprea Therapeutics Inc
2023/06/09	05 : 35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:APRE	Aprea Therapeutics Inc
2023/05/30	21 : 30	GlobeNewswire Inc.	Aprea Therapeutics to Present at BIO International Convention	NASDAQ:APRE	Aprea Therapeutics Inc
2023/05/16	05 : 48	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:APRE	Aprea Therapeutics Inc
2023/05/16	05 : 40	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:APRE	Aprea Therapeutics Inc
2023/05/16	05 : 05	GlobeNewswire Inc.	Aprea Therapeutics Reports First Quarter 2023 Financial Results and Provides Update on Business Operations	NASDAQ:APRE	Aprea Therapeutics Inc